Scientific controversy and asbestos: Making disease invisible

International Journal of Occupational and Environmental Health

Volumn 9, Issue 3, 2003, Pages 194-205

  Braun, Lundy ^a   Greene, Anna ^a   Manseau, Marc ^a   Singhal, Raman ^a   Kisting, Sophie ^b   Jacobs, Nancy ^a  

^a BROWN UNIVERSITY   (United States)

^b UNIVERSITY OF CAPE TOWN   (South Africa)

Author keywords

Asbestos; Asbestos related disease; Genetics; India; Safe use policies; South Africa; SV40 and mesothelioma

Indexed keywords

AMPHIBOLE; ASBESTOS; CHRYSOTILE; CARCINOGEN;

ASBESTOSIS; CHEMICAL COMPOSITION; FEMALE; GENETIC ASSOCIATION; HAZARDOUS WASTE; HUMAN; INDIA; INDUSTRIAL WORKER; INFORMATION DISSEMINATION; LUNG CANCER; MALE; MEDICAL RESEARCH; MESOTHELIOMA; MINING; OCCUPATIONAL EXPOSURE; POLICY; PREVALENCE; PRIORITY JOURNAL; REVIEW; SIMIAN VIRUS 40; SOUTH AFRICA; TRADE UNION; DEVELOPING COUNTRY; ENVIRONMENTAL EXPOSURE; GENETICS; INDUSTRY; KNOWLEDGE; RISK FACTOR; SCIENCE; VIROLOGY;

ASBESTOS; ASBESTOSIS; CARCINOGENS; DEVELOPING COUNTRIES; ENVIRONMENTAL EXPOSURE; HUMANS; INDIA; INDUSTRY; KNOWLEDGE; MESOTHELIOMA; OCCUPATIONAL EXPOSURE; PUBLIC POLICY; RISK FACTORS; SCIENCE; SOUTH AFRICA;

EID: 0142166224     PISSN: 10773525     EISSN: None     Source Type: Journal    
DOI: 10.1179/oeh.2003.9.3.194     Document Type: Review

References (72)

1. Brenson A. A surge in asbestos suits, many by healthy plaintiffs. New York Times, April 10, 2002, A1.
2. Brodeur P. Expendable Americans: The Incredible Story of How Tens of Thousands of American Men and Women Die Each Year of Preventable Industrial Disease. New York: Viking Press, 1974.
3. Ozonoff D. Failed warnings: asbestos-related disease and industrial medicine. In: Bayer R (ed). The Health and Safety of Workers: Case Studies in the Politics of Professional Responsibility. New York: Oxford University Press, 1988.
4. Castleman B. Asbestos: Medical and Legal Aspects. 4th ed. Englewood Cliffs, NJ: Aspen Law & Business, 1996.
5. Tweedale G. Magic Mineral to Killer Dust: Turner & Newall and the Asbestos Hazard. Oxford, U.K.: Oxford University Press, 2000.
6. McCulloch J. Asbestos Blues: Labour, Capital, Physicians, and the State in South Africa, Oxford, U.K.: James Currey Press, 2002.
7. Proctor R. Cancer Wars: How Politics Shapes What We Know and Don't Know About Cancer. New York: Basic Books, 1995.
8. Myers J. Asbestos and asbestos-related disease in South Africa. Working Paper No. 28, Cape Town, South Africa: South Africa Labour and Development Research Unit, 1980.
9. Felix M, Leger J-P, Ehrich I. Three minerals, three epidemics - asbestos mining and disease in South Africa. In: Mehlman MA, Upton A (eds). Advances in Modern Environmental Toxicology. Vol 22, Part 1. Princeton, NJ: Princeton Scientific Publishing Company, 1993: 265-86.
10. Davies J, Williams BG, Debeila MA, Davies DA. Asbestos-related lung disease among women in the Northern Province of South Africa. S Afr J Sci. 2001; 97:1-6.
11. The Asbestos Collaborative. Asbestos-Related Disease in South Africa: Opportunities and Challenges Remaining Since the 1998 Parliamentary Asbestos Summit, October 12, 2001.
12. Wagner J. Some pathological aspects of asbestos in the Union of South Africa. Proceedings of the Pneumoconiosis Conference, Johannesburg 1959. London, U.K.: J. & A. Churchhill, 1959.
13. Talent J., Harrison WO, Solomon A, Webster I. A survey of black mineworkers of the Cape crocidolite mines. In: Wagner WC (ed). Biological Effects of Mineral Fibres. Vol. 2. Lyon, France, International Agency for Research on Cancer, 1980: 723-30.
14. Myers J. The social context of occupational disease: asbestos in South Africa. Int J Health Serv. 1981; 11: 227-45.
15. Myers JE, Garisch D, Myers HS. A respiratory epidemiological study of stevedores intermittently exposed to asbestos in a South African port. Am J Ind Med. 1985; 7: 273-83.
16. Zwi AB, Reid G, Landau SP, Kielkowski D, Sitas F, Becklake MR. Mesothelioma in South Africa 1976-1984: incidence and case characteristics. Int J Epidemiol. 1989; 18:320-9.
17. Kielkowski D, Nelson G, Rees D. Risk of mesothelioma from exposure to crocidolite asbestos: a 1995 update of a South African mortality study. Occup Environ Med. 2000; 57:563-7.
18. Abdullah F, Jeebay M, Edwards D. Occupational disease in mines. Submission to the Commission of Inquiry on Mining Safety and Health. Industrial Health Research group, prepared for the National Union of Mineworkers, 1993.
19. Kisting S, Jeebay M, Abdullah F. Respiratory health surveillance programmes on asbestos mines in South Africa - Findings at medical audits over a five year period. Proceedings of the International Symposium on Epidemiology in Occupational Health. Harare, Zimbabwe, 1997.
20. Personal interview with Mr. Fred Gona, June 16, 2001.
21. National Asbestos Summit. The National Parliamentary Portfolio Committee on Environment and Tourism. Johannesburg SA, 1998.
22. Asbestos: Fibres of subterfuge. A toxic link briefing paper. January 2001.
23. Joshi TK. Report on status of asbestos industry in India. July 2001.
24. Langewiesche W. The ship breakers. The Atlantic Online, August 2000. 〈http://www.theatlantic.com/issues/2000/08/langewiesche2.htm〉. Accessed November 8, 2001.
25. Joshi V. Industrial safety concerns in the ship breaking industry/Alang-India. 1999. 〈http://www.csiwisepractices.org/?read= 85〉. Accessed November 10, 2001.
26. Burns JF. On an Indian shore where ships go to die, profit is law. New York Times. August 9, 1998.
27. Dave SK, Bhagia LJ, Mazumdar PK, Patel GC, Kulkarni PK, Kashyap SK. The correlation of chest radiograph and pulmonary function tests in asbestos miners and millers. Indian J Chest Dis Allied Sci. 1996; 38:81-9.
28. Smith S. Occupational safety and health in India: an attempt to estimate the real number of work related deaths. November 1999. 〈http://www.Isi.org. uk/indiaosh.shtml〉. Accessed November 6, 2001.
29. Environmental Protection Agency. Asbestos Health Effects Conference, May 24-25, 2001.
30. Noronha F. Indian unions, Greenpeace: toxic ship sneaked in Environment News Service, March 1999. 〈http://www.ban.org/ ban_news/indian_unions. html〉. Accessed January 11, 2003.
31. Jasanoff S. Science at the Bar: Law, Science, and Technology in America. Cambridge, MA: Harvard University Press, 1995.
32. The Asbestos Institute. From chrysotile to asbestos. 〈http://www. asbestos-institute.ca/presskit/press_1a.html〉. Accessed December 8, 2001.
33. The Asbestos Institute. About the Asbestos Institute. 〈http://www.chrysotile.com/en/about_ai.htm〉. Accessed December 17, 2002.
34. Bourrie M. Canada's deadly trade in asbestos. Third World Network. 〈http://www.twnside.org.sg/title/deadly-cn.htm〉. Accessed December 15, 2002.
35. The Asbestos Institute. Guidelines for a regulation on the safe and responsible use of chrysotile asbestos, 1999. 〈http://www.chrysotile.com/ en/regulat/guideln.htm〉. Accessed December 16, 2002.
36. Langer A. The health effects of chrysotile asbestos: contribution of science to risk management decisions. Summary of scientific workshop, September 14-16, 1997.
37. Natural Resources Canada. Goodale stands up for chrysotile asbestos industry. September 1997. 〈http://www.nrcan.gc.ca/media/newsreleases/1997/ 199768_e.htm〉. Accessed December 20, 2002.
38. Herman P, Thebaud-Mony A. Canada vs. France: WTO rules the asbestos conspiracy. The White Lung Association. 〈http://www.whitelung.org/jfalerts/ conspiracy.html〉. Accessed December 15, 2002.
39. The Asbestos Institute. Controlled use of asbestos - chrysotile: Brazil reiterates its commitment. October 2001. 〈http://www.chrysotile.com/en/ news/article.asp?ref=20011011〉. Accessed December 15, 2002.
40. Perron L, Morel-à-l'Huissier P. Chrysotile. Canadian Minerals Yearbook. 1997; 17.1-17.11.
41. The Asbestos Institute. Presentation to the Brazil Congress on Asbestos. June 2001. 〈http://www.chrysotile.com/en/news/article.asp?ref= 20010607〉. Accessed December 15, 2002.
42. Dupere J. Submission from Lab Chrysotile, Inc. Annual Canadian Mines and Energy Ministers Conference, Quebec City, PQ, Canada, September 10, 2001.
43. British Asbestos Newsletter. Issue 48, Autumn 2002. 〈http://www. lkaz.demon.co.uk/ban48.htm〉. Accessed December 15, 2002.
44. Siemiatycki J. Should Canadian health care professionals support the call for a worldwide ban on asbestos? Can Med Assoc J, 2001; 164:495-7.
45. Annals of the Global Asbestos Congress. Osasco, Brazil. September 17-20, 2000.
46. Shah K, Nathanson N. Human exposure to SV40: review and comment. Am J Epidemiol. 1976; 103:1-12.
47. Cicala C, Pompetti F, Carbone M. SV40 induces mesotheliomas in hamsters. Am J Pathol. 1993;142:1524-33.
48. Ke Y, Reddel RR, Gerwin BI, et al. Establishment of human in vitro mesothelial cell model system for investigating mechanisms of asbestos-induced mesothelioma. Am J Pathol. 1989; 134:979-91.
49. Carbone M, Pass HI, Rizzo P, et al. Simian Virus 40-like DNA sequences in human pleural mesothelioma. Oncogene. 1994; 9:1781-90.
50. Grady D. Study is unsure of tainted polio vaccine's cancer role. New York Times, October 23, 2002. A19.
51. Carbone M, Rizzo P, Pass HI. Simian virus 40, poliovaccines and human tumors: a review of recent developments. Oncogene. 1997; 15:1877-8.
52. Carbone M, Fisher S, Powers A, et al. New molecular and epidemiological issues in mesothelioma: role of SV40. J Cell Physiol. 1999; 180: 167-72.
53. Carbone M. Simian virus 40 and human tumors: it is time to study mechanisms. J Cell Biochem. 1999; 76:189-93.
54. Hirvonen A, Mattson K, Karjalainen A, et al. Simian virus 40 (SV40)-like DNA sequences not detectable in Finnish mesothelioma patients not exposed to SV40-contaminated polio vaccines. Molec Carcinogenesis. 1999; 26:93-9.
55. Xu L, Flynn BJ, Ungar S, et al. Asbestos induction of extended lifespan in normal human mesothelial cells: interindividual susceptibility and SV40 T antigen. Carcinogenesis. 1999; 20:773-83.
56. Pilatte Y, Vivo C, Renier A, et al. Absence of SV40 large T-antigen expression in human mesothelioma cell lines. Am J Res Cell Mol Biol. 2000; 23:788-93.
57. Shah K. Does SV40 infection contribute to the development of human cancer? Rev Med Virol. 2000; 10:31-43.
58. Shah KV, Rollison DE. Investigation of the SV40-human cancer association: look for the full signature of the virus. Dis Markers 2001; 17:159-61
59. Testa JR. Environmental, Viral, and Genetic Aspects of Mesothelioma. Seminar at Brown University, December 13, 2002.
60. Butel J, LednickyJA. Cell and molecular biology of simian virus 40: implications for human infections and disease. J Natl Cancer Inst. 1999; 91: 119-34.
61. Goldman M, Brock MJ. Contaminated polio vaccines: will the next shot be fired in the courtroom? J Legal Med. 1999; 20: 2.
62. Lawsuit against pharmaceutical company, brake shop alleges asbestos and SV40 virus-laced vaccine caused tumor. Vaccine Weekly. May 1, 2002. 〈http://www.newsrx.net〉.
63. Harris Martin: Study appears to eliminate asbestos as initiator of mesothelioma tumour. Chemical Business Newsbase. August 31, 2000.
64. Hoffman FL. Mortality from respiratory diseases in the dusty trades (inorganic dusts). Washington, DC: U.S. Bull Labor Statistics. No. 231, 1918: 172-80.
65. Nelkin D, Lindee MS. The DNA Mystique: The Gene as a Cultural Icon. New York: W. H. Freeman and Company, 1995.
66. Krousel T, Garcas N, Rothschild H. Familial clustering of mesothelioma: a report on three affected persons in one family. Am J Prev Med. 1986; 4:186-8.
67. Lewontin R. The Triple Helix: Gene, Organism, and Environment. Cambridge, MA: Harvard University Press, 2000.
68. Oyama S. Evolution's Eye: A Systems View of the Biology - Culture Divide (Science and Cultural Theory). Raleigh, NC: Duke University Press, 2000.
69. Fausto-Sterling A. Sexing the Body: Gender Politics and the Construction of Sexuality. New York, NY: Basic Books, 2002.
70. Roushdy-Hammady I, Siegal J, Emri S, et al. Genetic-susceptibility factor and malignant mesothelioma in the Cappadocian region of Turkey. Lancet. 2001; 357, 444-5.
71. Comaroff J. The diseased heart of Africa: medicine, colonialism, and the black body. In Lindenbaum S, Lock M (eds). Knowledge, Power, and Practice: The Anthropology of Medicine and Everyday Life. Berkeley CA: University of California Press, 1993.
72. Tomatis L. The IARC monographs program: changing attitudes towards public health. Int J Occup Environ Health. 2002; 8:144-152.